GlaxoSmithKline Pharma receives GST order for ₹35 Lakhs for FY22

GlaxoSmithKline Pharmaceuticals Limited has received an order dated 31st December 2025 from the Maharashtra State GST authorities concerning the Financial Year 2021-22. The order pertains to the Assis...

GlaxoSmithKline Pharmaceuticals Limited has received an order dated 31st December 2025 from the Maharashtra State GST authorities concerning the Financial Year 2021-22. The order pertains to the Assistant Commissioner of State Tax, Mumbai, Maharashtra, and involves a total demand of ₹35,07,895/-, comprising ₹18,16,196/- in tax, ₹15,10,080/- in interest, and ₹1,81,619/- in penalty. The demand has been raised in relation to GST credit issues, specifically a mismatch between the Company’s GST returns and the details reported by its suppliers. The company has stated that this order is not expected to have any impact on its financial operations. GlaxoSmithKline Pharmaceuticals Limited is currently evaluating the demand order and will take appropriate actions in due course.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is GlaxoSmithKline Pharmaceuticals Limited in the news today?

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is in the news due to the company received a gst demand order, which is a regulatory action. while it involves a financial demand, the company has stated there is no impact on its operations and is evaluating the order, making the sentiment neutral.

Other Regulatory FilingsTaxation
GlaxoSmithKline Pharmaceuticals LimitedGLAXOhttps://prysm.fi/v2/analyze/GLAXO

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

GlaxoSmithKline Pharma receives GST order for ₹35 Lakhs for FY22

January 1, 2026, 09:01 AM

AI Sentiment Analysis

Top Queries to Ask About GlaxoSmithKline Pharmaceuticals Limited

More Details on This News

GlaxoSmithKline Pharmaceuticals Limited has received an order dated 31st December 2025 from the Maharashtra State GST authorities concerning the Financial Year 2021-22. The order pertains to the Assistant Commissioner of State Tax, Mumbai, Maharashtra, and involves a total demand of ₹35,07,895/-, comprising ₹18,16,196/- in tax, ₹15,10,080/- in interest, and ₹1,81,619/- in penalty.

The demand has been raised in relation to GST credit issues, specifically a mismatch between the Company’s GST returns and the details reported by its suppliers. The company has stated that this order is not expected to have any impact on its financial operations. GlaxoSmithKline Pharmaceuticals Limited is currently evaluating the demand order and will take appropriate actions in due course.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on GlaxoSmithKline Pharmaceuticals Limited

Discover more trending news on Prysm

View All